MTOR inhibitors are widely used in many GU cancers and in kidney transplantations. mTOR inhibitors are known to cause proteinuria and many cases of biopsy proven FSGS, collapsing GN and TMA. There is always a risk of AIN with any drug. Of note, recently, in a manuscript in the Ann of Oncology, Izzedine et al present 4 cases of biopsy proven ATN from mTOR inhibitors.
A kidney biopsy showed acute tubular necrosis (ATN) with prominent tubular dysfunction. Withdrawal of the drug leads to a rapid recovery in two cases. However, a fixed renal dysfunction was noted in the other two cases, one of which will remained dialysis-dependent. Two cases used A TORC1/TORC2 inhibitor and one case of everolimus and one of temsirolimus.
A toxicity to watch out for all transplant and onco-nephrologists.
Friday, August 30, 2013
Thursday, August 29, 2013
TOPIC DISCUSSION: Risk factors for UTI in Transplant patients
What are independent risk factors for early urinary tract infections in renal transplants?
1. Female Gender
2. Prolonged use of foley
3. Stent use
4. Older age
5. Delayed Graft function.
These findings are summarized in a recent study by Lee et al. Interestingly, they also found that untreated UTI was associated with risk of acute cellular rejection.
1. Female Gender
2. Prolonged use of foley
3. Stent use
4. Older age
5. Delayed Graft function.
These findings are summarized in a recent study by Lee et al. Interestingly, they also found that untreated UTI was associated with risk of acute cellular rejection.
Labels:
infections,
kidney transplantation
Wednesday, August 28, 2013
Dr. House, Sherlock Holmes and Medical Education
Medical TV shows such as Dr. House and detective books such as of Watson and Holmes have now entered medical education literature to deduce their use in deductive reasoning and diagnostic skills. Can they be used to teach students about diagnosis and how to think? Dr. House exemplifies rare diseases states most of the episodes presenting even in a more atypical manner. Can this teach students to diagnose more common entities?
A recent study in AJM this year from France analyzed 18 episodes of Dr.House and found that strategies used in the show were unrealistic and there is an information bias in the show and costs, risks and failures of treatments are not taken into account. Here is another perspective on this topic.
Interesting to see a physician's account of each and every episode of Dr.House.
Regardless of the shortcomings, many of us get joy and excitement from watching the sleuth diagnose yet another rare disorder: and to top it all- he is a framed as a board certified specialist in infectious disease and nephrology!!
A recent study in AJM this year from France analyzed 18 episodes of Dr.House and found that strategies used in the show were unrealistic and there is an information bias in the show and costs, risks and failures of treatments are not taken into account. Here is another perspective on this topic.
Interesting to see a physician's account of each and every episode of Dr.House.
Regardless of the shortcomings, many of us get joy and excitement from watching the sleuth diagnose yet another rare disorder: and to top it all- he is a framed as a board certified specialist in infectious disease and nephrology!!
Labels:
Funny stuff,
general medicine
Sunday, August 18, 2013
Message from the NRAA regarding a medical director workshop meeting in Fall 2013.
NRAA
Announces Physician Panel for Medical Director Workshop & Nephrology
Symposium
NRAA, introduces the
physician-led panel for the Medical Director Workshop & Nephrology
Symposium at the 2013 NRAA Annual
Conference, in joint sponsorship with the Cleveland Clinic, on September 25, 2013,
in Seattle, WA.
The NRAA has gathered expert speakers to offer a Physicians’ Track for
Dialysis providers. This unique
opportunity brings colleagues and industry experts together to discuss
improving patient care, USRDS trends and key findings, and an open forum for
providers to share best practices.
Allan Collins, MD, FACP will give an overview of CMO symposium and lead a
discussion about the problem from the USRDS perspective. Richard Glassock, MD will advise about when to start and what not
to do, in addition to sharing recommendations on volume management.
Diane Wish will address how to decrease hospitalization
rates. Brigitte Schiller, MD, FACP, FASN will co-present with Doug Johnson, MD on how to increase PD
among ESRD patients and discuss nutritional supplements and sodium management
with Raymond Hakim, MD.
Leanna B. Tyshler, MD and Doug
Johnson, MD plan to address CKD Education, followed by a discussion on
Urgent Start Peritoneal Dialysis with Steven
Guest, MD and Leanna B. Tyshler, MD.
These nephrology experts will provide a platform to discuss what the
future holds for the treatment of kidney disease. This workshop is a must for all medical
directors who aim to improve dialysis organizations.
Friday, August 16, 2013
Frail Renal Phenotype
Frailty in the elderly or any patient leading towards ESRD is a tough combination. Renal physicians should not consider dialysis as the de facto treatment for all patients and in certain patients that meet some frailty criteria, perhaps non dialysis modalities with multi team approach and renal palliative care might be better options. Recent article in CJASN explores the Frail Renal Phenotype
1. Karnofsky score <50( requires special care)
2. Older age compared 80-84 : 85-89 years
3. Presence of geriatric factors and syndromes: Dementia, non ambulatory status, positive frailty test, low serum albumin, symptom burden that is high.
4. " Would you be surprised if this patient died in the next year?" answer being No
5. Low survival probability by comorbid scores, hemodialysis mortality index, and nursing four chronic conditions and nursing home patient.
Take a look at the full article at CJASN 2013
1. Karnofsky score <50( requires special care)
2. Older age compared 80-84 : 85-89 years
3. Presence of geriatric factors and syndromes: Dementia, non ambulatory status, positive frailty test, low serum albumin, symptom burden that is high.
4. " Would you be surprised if this patient died in the next year?" answer being No
5. Low survival probability by comorbid scores, hemodialysis mortality index, and nursing four chronic conditions and nursing home patient.
Take a look at the full article at CJASN 2013
Labels:
CKD and ESRD,
palliative care
Thursday, August 15, 2013
Coffee, tea, or soda: are they going to cause kidney stones?
Beverages and risk of kidney stones has been a recently studied topic.
Recently published studies and most recent being in CJASN by Curhan's group suggested the following:
1. Sugar sweetened sodas was associated with higher incidence of stones( as fructose increased urinary ca excretion and uric acid excretion).
2. Consumption of sugar sweet soda and punch was associated with highest risk of stone formation.
3. Coffee and tea drinking was associated with lower risk of stone formation( coffee and tea act as diuretics and diuresis via both proximal and distal tubules)- mainly due to caffeine related effect.
4. Interestingly, decaffeinated coffee was also associated with lower incidence of stones ( perhaps an anti oxidant effect suggested by the authors)
5. Wine and alcohol ingestion was associated with lower incidence of stones( diuretic effect)- interesting find but still needs to be studied further.
6. Orange juice intake was associated with lower incidence of stones( has K citrate and fructose in it). K citrate wins out! Some juices such as apple juice has more fructose than K citrate and hence there have been more stones in those drinkers.
Tuesday, August 13, 2013
Consult Rounds: Psoriasis and kidney disease
Psoriasis is an immune-mediated chronic
inflammatory disorder of the skin. Association with kidney disease has been
debated for a long time. Secondary renal amyloidosis in psoriatic arthropathy
and drug-induced renal lesions secondary to methotrexate or cyclosporine are
accepted accompaniments of
psoriasis.
IgA nephropathy is also known to occur in psoriatic patients with HLA B27
genetic sharing.
Are
there GN that have been associated with psoriasis. One interesting report I
found describes three findings: IgA, FSGS and membranous GN. All of them
improved with treatment of the skin condition and ACEI/ARB therapy. The authors
label the entity as ‘‘psoriatic
nephropathy’’ or ‘‘psoriatic kidney disease.’’ but with some doubt
and a "?"
Other studies have looked at this association.
Microalbuminuria has been studied as a potential link with psoriasis.
In that one study, when abnormal urinary findings were compared to another
cohort, patients with psoriasis had an increased prevalence of pathologic albuminuria
compared with controls. Of the eight
patients with psoriasis who had urinary abnormalities, four underwent
renal biopsy. Two of them had biopsy-proven glomerulonephritis: mesangial
proliferative glomerulonephritis in one and IgA nephropathy in the other. Another study had looked at this connection.
But
recently in JAMA
dermatology, psoriasis
was linked with many co morbid conditions including kidney disease. In a large
cohort of over 9,000 patients, psoriasis overall was
associated with higher prevalence of chronic pulmonary disease, diabetes
mellitus, diabetes with systemic complications, mild liver disease , myocardial
infarction, peptic ulcer disease ,peripheral vascular disease , renal
disease , and rheumatologic disease. Trend analysis revealed significant
associations between psoriasis severity
and each of the above comorbid diseases. Potential confounding factors, such as
hypertension, diabetes, and the use of nephrotoxic psoriasis treatments should
be kept in mind when making this connection. A topic worth further studying.
Subscribe to:
Posts (Atom)